David Crean
Director/Board Member bij HISTOGEN INC.
Vermogen: - $ op 29-02-2024
Profiel
Founder of Cardiff Advisory LLC, David H.
Crean is a businessperson who has been at the head of 6 different companies and currently occupies the position of Chairman & President at Alzheimer's Association Northern California & Northern Nevada, President & Chief Executive Officer for Coast Bioventures LLC and Managing Partner at Cardiff Advisory LLC.
Dr. Crean is also Chief Business Officer of MediciNova, Inc., Member of Securities Investor Protection Corp., Member of Corporate Directors Forum, Member of Financial Industry Regulatory Authority, Inc. and Partner at Mesa Verde Venture Partners LP and on the board of 6 other companies.
In the past he occupied the position of Chairman for Phoenix Molecular Designs Ltd., Chief Executive Officer & Director at Talapo Therapeutics, Inc., Managing Director at Objective Capital Partners LLC, Vice President-Corporate Development of Almirall LLC and President & Chief Executive Officer for Boys & Girls Clubs of San Dieguito.
David H.
Crean received an MBA from Pepperdine Graziadio Business School, a doctorate and a graduate degree from State University of New York at Buffalo and an undergraduate degree from Canisius College.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
HISTOGEN INC.
-.--% | 20-06-2023 | 0 ( -.--% ) | - $ | 29-02-2024 |
Actieve functies van David Crean
Bedrijven | Functie | Begin |
---|---|---|
HISTOGEN INC. | Director/Board Member | 08-11-2021 |
MEDICINOVA, INC. | Corporate Officer/Principal | 01-05-2021 |
California Life Sciences Association
California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Director/Board Member | 01-11-2018 |
Mesa Verde Venture Partners LP
Mesa Verde Venture Partners LP Investment ManagersFinance Mesa Verde Venture Partners LP seeks investment opportunities in companies located in the US. The fund targets companies operating in the fields of drug discovery/tools, medical devices & diagnostics and healthcare information technology. It provides financing for early stage capital requirements with an investment size of $0.5 - $1.5 million per company. | Corporate Officer/Principal | - |
Securities Investor Protection Corp.
Securities Investor Protection Corp. Insurance Brokers/ServicesFinance The Securities Investor Protection Corporation either acts as trustee or works with an independent court-appointed trustee in a missing asset case to recover funds. The statute that created SIPC provides that customers of a failed brokerage firm receive all non-negotiable securities that are already registered in their names or in the process of being registered. Recovered funds are used to replenish SIPC's reserve in the event that the reserve is tapped in the early stages of a liquidation proceeding. | Corporate Officer/Principal | - |
Financial Industry Regulatory Authority, Inc.
Financial Industry Regulatory Authority, Inc. Investment Banks/BrokersFinance Financial Industry Regulatory Authority, Inc. engages in the provision of securities regulation, complementary compliance, and technology-based services. Its services include writing and enforcing rules governing the activities of securities firms with brokers, examining firms for compliance with those rules, fostering market transparency, and educating investors. The company was founded in 2007 and is headquartered in Washington, DC. | Corporate Officer/Principal | - |
Paracrine, Inc.
Paracrine, Inc. BiotechnologyHealth Technology Paracrine, Inc. is a biotechnology company that is developing a device-based autologous multifactorial cell therapy platform to treat chronic conditions. The private company is based in San Diego, CA. The company's cell therapy platform has multiple mechanisms of action that can address the underlying pathology of several debilitating chronic diseases. Paracrine is currently advancing multiple late-stage ide clinical trials based on robust prior data. The CEO of the company is Christopher James Calhoun. | Director/Board Member | 12-05-2022 |
BIOCOM
BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Director/Board Member | 23-02-2022 |
Alzheimer's Association Northern California & Northern Nevada | Chairman | - |
░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░ ░░ ░░░░░░ ░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
░░░░░░░░░ ░░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░ | - |
Eerdere bekende functies van David Crean
Bedrijven | Functie | Einde |
---|---|---|
░░░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░░ ░░░░░ ░░░░░ ░░ ░░░ ░░░░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
░░░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░ | - |
Opleiding van David Crean
Canisius College | Undergraduate Degree |
State University of New York at Buffalo | Doctorate Degree |
Pepperdine Graziadio Business School | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
MEDICINOVA, INC. | Health Technology |
HISTOGEN INC. | Health Technology |
Bedrijven in privébezit | 17 |
---|---|
Almirall LLC
Almirall LLC Pharmaceuticals: MajorHealth Technology Almirall LLC manufactures and distributes pharmaceutical products. Its products include tablets, gel, ointment, lotion, and topical cream. The company was founded by Jay Gooding and Craig Ballaron in 2004 and is headquartered in Exton, PA. | Health Technology |
BIOCOM
BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Commercial Services |
Securities Investor Protection Corp.
Securities Investor Protection Corp. Insurance Brokers/ServicesFinance The Securities Investor Protection Corporation either acts as trustee or works with an independent court-appointed trustee in a missing asset case to recover funds. The statute that created SIPC provides that customers of a failed brokerage firm receive all non-negotiable securities that are already registered in their names or in the process of being registered. Recovered funds are used to replenish SIPC's reserve in the event that the reserve is tapped in the early stages of a liquidation proceeding. | Finance |
Corporate Directors Forum
Corporate Directors Forum Miscellaneous Commercial ServicesCommercial Services Corporate Directors Forum operates as a forum for corporate directors. The non-profit company is based in La Jolla, CA. | Commercial Services |
Financial Industry Regulatory Authority, Inc.
Financial Industry Regulatory Authority, Inc. Investment Banks/BrokersFinance Financial Industry Regulatory Authority, Inc. engages in the provision of securities regulation, complementary compliance, and technology-based services. Its services include writing and enforcing rules governing the activities of securities firms with brokers, examining firms for compliance with those rules, fostering market transparency, and educating investors. The company was founded in 2007 and is headquartered in Washington, DC. | Finance |
Association for Corporate Growth of Orange County | |
Histogen, Inc. /Old/
Histogen, Inc. /Old/ Medical/Nursing ServicesHealth Services Histogen, Inc. is a regenerative medicine company. It focuses on developing patented technologies that replace and regenerates tissues in the body. The firm's applications include hair stimulating complex, matrix regeneration, and skin care. The company was founded in 2007 and is headquartered in San Diego, CA. | Health Services |
Mesa Verde Venture Partners LP
Mesa Verde Venture Partners LP Investment ManagersFinance Mesa Verde Venture Partners LP seeks investment opportunities in companies located in the US. The fund targets companies operating in the fields of drug discovery/tools, medical devices & diagnostics and healthcare information technology. It provides financing for early stage capital requirements with an investment size of $0.5 - $1.5 million per company. | Finance |
Alzheimer's Association Northern California & Northern Nevada | |
Objective Capital Partners LLC
Objective Capital Partners LLC Investment ManagersFinance Objective Capital Partners LLC is an investment banking and valuation company that specializes in providing tenacious investment banking services for middle-market companies. The private company is based in San Diego, CA. The company's services include sell-side M&A, valuation, buy-side M&A, capital raise, and strategic planning. | Finance |
Talapo Therapeutics, Inc.
Talapo Therapeutics, Inc. BiotechnologyHealth Technology Talapo Therapeutics, Inc. operates as a biotechnology company. The company is headquartered in The company is headquartered in, CA. | Health Technology |
Phoenix Molecular Designs Ltd.
Phoenix Molecular Designs Ltd. Miscellaneous Commercial ServicesCommercial Services Phoenix Molecular Designs operates as a biopharmaceutical company. It focuses on developing first-in-class inhibitors against ribosomal S6 kinase (RSK), an important drug target for cancer, heart disease, and inflammation. The company was founded by Sandra Dunn in 2012 and is headquartered in Vancouver, Canada. | Commercial Services |
California Life Sciences Association
California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Commercial Services |
Boys & Girls Clubs of San Dieguito | |
Coast Bioventures LLC | |
Cardiff Advisory LLC | |
Paracrine, Inc.
Paracrine, Inc. BiotechnologyHealth Technology Paracrine, Inc. is a biotechnology company that is developing a device-based autologous multifactorial cell therapy platform to treat chronic conditions. The private company is based in San Diego, CA. The company's cell therapy platform has multiple mechanisms of action that can address the underlying pathology of several debilitating chronic diseases. Paracrine is currently advancing multiple late-stage ide clinical trials based on robust prior data. The CEO of the company is Christopher James Calhoun. | Health Technology |